Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • Subscribe to Print Magazine
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Channel Makeover Bioengineered to Switch Off Neurons

April 25, 2014 By National Institutes of Health

Leaps orders of magnitude beyond existing tools — NIH study

Researchers transformed an excitatory cellular channel borrowed from algae (above left) into a powerful inhibitory channel (lower right) that allows for precise experimental turning-off of neurons. (Credit: Andre Berndt, Ph.D., Soo Yeun Lee, Ph.D., Charu Ramakrishnan, and Karl Deisseroth, M.D., Ph.D., Stanford University)Scientists have bioengineered, in neurons cultured from rats, an enhancement to a cutting edge technology that provides instant control over brain circuit activity with a flash of light. The research funded by the National Institutes of Health adds the same level of control over turning neurons off that, until now, had been limited to turning them on.

“What had been working through a weak pump can now work through a highly responsive channel with many orders of magnitude more impact on cell function,” explained Karl Deisseroth, M.D., Ph.D., of Stanford University, Stanford, Calif.

It is like going from a squirt to a gushing hose.

Deisseroth and colleagues report on what is being hailed as a marvel of genetic engineering in the April 25, 2014 issue of the journal Science.

“This latest discovery by the Deisseroth team is the type of neurotechnology envisioned by President Obama when he launched the BRAIN Initiative a year ago,” said Thomas R. Insel, M.D., director of the National Institute of Mental Health, a funder of the study. “It creates a powerful tool that allows neuroscientists to apply a brake in any specific circuit with millisecond precision, beyond the power of any existing technology. This will be vital for understanding brain circuits involved in behavior, thinking, and emotion.”

Deisseroth’s team had pioneered the use of light pulses to control brain circuitry in animals genetically engineered to be light-responsive — optogenetics. Genes that allow the sun to control light-sensitive primitive organisms like algae, melded with genes that make fluorescent marker proteins, are fused with a deactivated virus that delivers them to specific types of neurons which they become part of — allowing pulses of light to similarly commandeer brain cells.

When a neuron fires depends on the balance of ions flowing across the cell membrane, so being able to experimentally control this cellular machinery is critical for understanding how the brain works. But until now, the optogenetic tools for turning off neurons have been much less powerful than for turning them on — a weak inhibitory pump, moving only one ion per photon of light, versus an efficient excitatory channel.

Stanford bioengineers and their colleagues recently discovered the crystal structure of channelrhodopsin, the protein borrowed from algae to achieve optogenetic control of neurons. To transform this excitatory channel into an effective inhibitory channel, the team systematically introduced mutations into the channel’s gene, gradually reshaping its structure through molecular engineering into one with optimal inhibitory properties. To become an effective inhibitory channel, its central pore needed to be lined with positive instead of negatively charged amino acids to be converted from a cation (positive ion)-conducting into an anion (negative ion) -conducting channel.

It turns out that there are economies of scale afforded by the transformed channel — the more the inhibition, the less light required to achieve the desired biological effect. This raises possible future therapeutic applications, such as in the management of pain, said Deisseroth.

The study was also funded, in part, by the NIH’s National Institute on Drug Abuse.

Related Articles Read More >

Minnetronix Medical's MindsEye expandable port is a cone-shaped device for deep brain access
Contract manufacturer Minnetronix Medical launches its first in-house product, MindsEye
A rat holding its face with its paws
Ultrasound research with rats shows potential for depression therapy
Tivic Health CEO Jennifer Ernst
Sinus pain is just the beginning for Tivic Health’s CEO
A series of before-and-after brain scans showing improvement in long COVID patients after hyperbaric oxygen therapy
Long COVID study finds potential in hyperbaric oxygen therapy

DeviceTalks Weekly.

August 12, 2022
DTW – Medtronic’s Mauri brings years of patient care to top clinical, regulatory, scientific post
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • Subscribe to Print Magazine
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech